Alder Matthias - Insider Non-Derivative Transactions at Gain Therapeutics, Inc. (GANX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 26, 2024, Alder Matthias's relationship to Gain Therapeutics, Inc. (GANX) is Director,Officer (Chief Executive Officer), and currently has 27,225 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other GANX insiders.
Data Source: SEC.
Alder Matthias - Insider Non-Derivative Transactions of GANX Common Stock
Alder Matthias - Insider Non-Derivative Transactions at GANX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 27, 2024 | F -- (Common Stock) | 6085 | 4.06 | 21140 |
| Mar 27, 2024 | M -- (Common Stock) | 18750 | 0 | 25763 |
| Mar 27, 2024 | M -- (Common Stock) | 825 | 0 | 26588 |
| Mar 27, 2024 | M -- (Common Stock) | 637 | 0 | 27225 |
| Dec 22, 2023 | Sell -- (Common Stock) | 206 | 2.46 | 5286 |
| Dec 21, 2023 | M -- (Common Stock) | 637 | 0 | 5492 |
| Dec 8, 2023 | Sell -- (Common Stock) | 1820 | 2.5 | 4855 |
| Oct 2, 2023 | M -- (Common Stock) | 825 | 0 | 6675 |
| Sep 21, 2023 | M -- (Common Stock) | 2550 | 0 | 5850 |
| Jul 2, 2023 | M -- (Common Stock) | 3300 | 0 | 3300 |